Companies

Dr. Martens CEO signals confidence with share purchase

Jun 26, 2026 United Kingdom

Ije Nwokorie's purchase of 112,500 shares follows Dr. Martens’ return to profit growth in FY26, signalling confidence as the British footwear company prepares to move from stabilisation to scaling

Dr. Martens’ Chief Executive Officer, Ije Nwokorie, has purchased 112,500 ordinary shares in the British footwear company, in a move that signals confidence in the brand’s direction. The total transaction value was around 85.6 thousand pounds (99.3 thousand euros).

The purchase follows the company’s latest annual results, which showed a return to profit growth despite a decline in revenue. In fiscal 2026, profit before tax rose by 9.7% to 32.7 million pounds (37.9 million euros), compared with 29.8 million pounds (33.5 million euros) a year earlier.

Revenue, however, fell by 1.5% over the same period, reaching 764.9 million pounds (887.8 million euros). The figures suggest that the company improved profitability even as sales remained under pressure.

Dr. Martens has described fiscal 2025 as a year of stabilisation, followed by a shift in fiscal 2026 towards a more consumer-first approach. After returning to profit growth, the company is now preparing to focus on scaling the business in fiscal 2027.

Nwokorie has acknowledged that further work remains in repositioning the business, but said the next stage of the strategy will centre on scaling. His share purchase adds confidence to that message.

1 GBP = 1.16 EUR

Image Credits: drapersonline.com

United Kingdom Brands Companies Dr. Martens Footwear Management